REPLIGEN CORP - COMMON STOCK (RGEN)

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
49,757,404
Share change
+669,580
Total reported value
$9,314,767,665
Put/Call ratio
64%
Price per share
$187.11
Number of holders
413
Value change
+$136,192,623
Number of buys
194
Number of sells
186

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2022

As of 30 Sep 2022, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 413 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,757,404 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Invesco Ltd., BROWN CAPITAL MANAGEMENT LLC, SANDS CAPITAL MANAGEMENT, LLC, WCM INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, Artisan Partners Limited Partnership, and AMERIPRISE FINANCIAL INC. This page lists 416 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.